eli lilly glp-1 dominance to seek approval of new weight-loss drug this year Eli Lilly Hits $1.01 Trillion

Potential new therapeutic target for alzheimers disease: Glucagon-like peptide-1

44 evaluated the effect of caffeine intake on potential cardiovascular disease outcomes and showed that typical moderate caffeine intake was not associated with an increased risk of overall cardiovascular disease

Brief room-temperature exposure during normal handling is usually unavoidable

Many patients choose the package option to support weekly wellness treatments

I laboratoriet programmerar vi om dessa celler till pluripotenta stamceller som kan utvecklas till vilken celltyp som helst och vi gr om dem till insulinproducerande betaceller